Single-cell analysis identifies Ifi27l2a as a novel gene regulator of microglial inflammation in the context of aging

Gab Seok Kim1, Elisabeth Harmon1, Manuel Gutierrez2

  • 1The University of Texas Health Science Center at Houston.

Research Square
|February 24, 2023
PubMed

Insights

Researchers identified Ifi27l2a as a key gene modulating microglial function and neuroinflammation after stroke. Reducing Ifi27l2a shows potential for protecting the aged brain and improving stroke outcomes.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Microglia are crucial for brain inflammation, balancing pro-inflammatory and reparative functions.
  • Identifying genes that regulate microglial activity is vital for developing stroke therapies.
  • Stroke involves significant neuroinflammation, impacting aged brains disproportionately.

Approach:

  • Single-cell RNA sequencing was used on aged mouse brains post-stroke to identify differentially expressed genes.
  • Ifi27l2a upregulation in microglia was confirmed through various experimental models, including human samples.
  • In vitro studies investigated the functional role of Ifi27l2a in microglial inflammatory responses.

Key Points:

  • Ifi27l2a, typically involved in viral defense, was significantly upregulated in microglia following stroke.
  • Overexpression of Ifi27l2a in microglia promoted neuroinflammation via reactive oxygen species.
  • Hemizygous deletion of Ifi27l2a reduced stroke-induced gliosis and neuroinflammation, highlighting gene dosage effects.

Conclusions:

  • Ifi27l2a acts as a novel regulator of microglial function and neuroinflammation in aged brains, particularly after ischemic stroke.
  • Targeting Ifi27l2a presents a potential therapeutic strategy for cerebral protection in stroke patients.
  • Further research into Ifi27l2a's role could unlock new treatments for inflammatory neurodegenerative diseases.

Related Concept Videos